PMID: 9553645Apr 29, 1998Paper

The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies

American Journal of Reproductive Immunology : AJRI
G SherW Ching

Abstract

To compare the effect of heparin/aspirin therapy alone vs. heparin/aspirin in combination with intravenous immuno-globulin (IVIg) immunotherapy on in vitro fertilization (IVF) outcome of patients who test positive for antithyroid antibodies (ATAs). Eighty-two women younger than 40 years of age whose infertility was related exclusively to female causes were evaluated. All tested positive for organ-specific antithyroid antibodies (antimicrosomal and/or antithyroglobulin antibodies), but negative for antiphospholipid antibodies. Thirty-seven of these women (group A) received H/A alone, whereas 45 (group B) received heparin/aspirin in combination with IVIg. Ten (27%) of women in group A and 23 (51%) of women in group B achieved live births after completion of a single IVF/embryo transfer cycle (P = 0.027). We conclude that IVIg therapy significantly improves IVF success rates in ATA+ women.

Citations

Sep 26, 2000·Fertility and Sterility·J A Hill, R T Scott
Jun 2, 2005·Journal of Experimental & Clinical Assisted Reproduction·Bradley S HurstMichelle L Matthews
Mar 31, 2009·Human Fertility : Journal of the British Fertility Society·Luciano G NardoUNKNOWN Policy & Practice Committee of the British Fertility Society
Feb 17, 2007·Clinical Endocrinology·Kris PoppeDaniel Glinoer
Mar 14, 2008·American Journal of Reproductive Immunology : AJRI·David A Clark
Dec 15, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·A R Ahmed, H M Gürcan
May 26, 2004·Best Practice & Research. Clinical Endocrinology & Metabolism·Alex Stagnaro-Green, Daniel Glinoer
Jul 28, 2012·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Paolo Giovanni ArtiniVito Cela
Apr 30, 2016·Taiwanese Journal of Obstetrics & Gynecology·Hui HeGe Lin
Mar 15, 2016·American Journal of Hematology·Eric M AmmannElizabeth A Chrischilles
May 29, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Kris PoppeDaniel Glinoer
Feb 26, 2005·Annals of the New York Academy of Sciences·P E Levi SettiE Ferrazzi
Nov 4, 2017·Systems Biology in Reproductive Medicine·Majid AhmadiMehdi Yousefi
Mar 29, 2001·Thyroid : Official Journal of the American Thyroid Association·J Abramson, A Stagnaro-Green
Jan 28, 2016·Clinical and Experimental Reproductive Medicine·Moon Kyoung Cho
Mar 1, 2008·Expert Review of Endocrinology & Metabolism·Gerasimos E KrassasAthina Kaprara
Mar 22, 2020·American Journal of Reproductive Immunology : AJRI·Jilai XieMin Jin
Jul 15, 2003·Current Opinion in Obstetrics & Gynecology·Caleb B Kallen, Aydin Arici
May 20, 2000·Annals of the New York Academy of Sciences·J HorejsíM Brandejska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.